On 2025-08-12, Eupraxia Pharmaceuticals Inc. (EPRX) announced earnings per share of $-0.26 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-0.21.
The next expected annoucement date for quarterly earnings is 2025-11-06, with an average estimated earnings per share of $-0.22 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-12 | 2025-06-30 | $-0.21 | $-0.26 |
| 2025-05-06 | 2025-03-31 | $-0.19 | $-0.21 |
| 2025-03-20 | 2024-12-31 | -- | $-0.21 |
| 2024-11-07 | 2024-09-30 | -- | $-0.17 |
| 2024-08-07 | 2024-06-30 | -- | $-0.17 |
| 2024-05-08 | 2024-03-31 | -- | $-0.21 |
| 2024-04-01 | 2023-12-31 | -- | $-0.17 |
| 2023-11-14 | 2023-09-30 | -- | $-0.26 |
| 2023-08-11 | 2023-06-30 | -- | $-0.36 |
| 2023-05-11 | 2023-03-31 | -- | $-0.23 |